Alex Nachman

1.6k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

Alex Nachman is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alex Nachman has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in Alex Nachman's work include Immune Response and Inflammation (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Protein Degradation and Inhibitors (2 papers). Alex Nachman is often cited by papers focused on Immune Response and Inflammation (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Protein Degradation and Inhibitors (2 papers). Alex Nachman collaborates with scholars based in United States, Canada and Japan. Alex Nachman's co-authors include Alan Aderem, Thomas R. Hawn, Kelly D. Smith, Annelies Verbon, Bruce Beutler, Shuying Sue Li, Lue Ping Zhao, Shawn Skerrett, Lea Schroeder and Kamilla D. Lettinga and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Alex Nachman

12 papers receiving 1.2k citations

Hit Papers

A Common Dominant TLR5 Stop Codon Polymorphism Abolishes ... 2003 2026 2010 2018 2003 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Nachman United States 11 608 312 289 135 125 13 1.2k
Rose Kulhavy United States 23 717 1.2× 670 2.1× 179 0.6× 70 0.5× 71 0.6× 43 1.7k
Claudio Cortés United States 23 1.1k 1.8× 297 1.0× 235 0.8× 38 0.3× 48 0.4× 50 1.8k
Chantal Tougne Switzerland 21 1.0k 1.7× 305 1.0× 427 1.5× 41 0.3× 102 0.8× 31 1.7k
Claire Jones United Kingdom 20 605 1.0× 465 1.5× 174 0.6× 189 1.4× 60 0.5× 36 1.3k
Elodie Mohr United Kingdom 21 1.0k 1.6× 306 1.0× 199 0.7× 80 0.6× 90 0.7× 32 1.5k
Edmund J. Gosselin United States 21 1.0k 1.7× 683 2.2× 242 0.8× 35 0.3× 117 0.9× 51 1.9k
Björn Frendéus Sweden 22 735 1.2× 557 1.8× 658 2.3× 382 2.8× 255 2.0× 57 1.8k
Sukanya Raghavan Sweden 28 1.2k 2.0× 270 0.9× 195 0.7× 120 0.9× 217 1.7× 49 1.9k
Lijun Xin United States 23 1.2k 1.9× 247 0.8× 461 1.6× 45 0.3× 124 1.0× 35 2.0k
Jeroen D. Langereis Netherlands 23 634 1.0× 352 1.1× 516 1.8× 43 0.3× 130 1.0× 74 1.5k

Countries citing papers authored by Alex Nachman

Since Specialization
Citations

This map shows the geographic impact of Alex Nachman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Nachman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Nachman more than expected).

Fields of papers citing papers by Alex Nachman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Nachman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Nachman. The network helps show where Alex Nachman may publish in the future.

Co-authorship network of co-authors of Alex Nachman

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Nachman. A scholar is included among the top collaborators of Alex Nachman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Nachman. Alex Nachman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nachman, Alex, et al.. (2025). Infectious Diseases: What You May Have Missed in 2024. Annals of Internal Medicine. 178(5_Supplement). S54–S73.
2.
Nathan, Paul C., Alex Nachman, Rinku Sutradhar, et al.. (2018). Adverse mental health outcomes in a population‐based cohort of survivors of childhood cancer. Cancer. 124(9). 2045–2057. 56 indexed citations
3.
Dove, Peter, Aisha Shamas‐Din, Alex Nachman, et al.. (2015). FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. Cell Death and Disease. 6(7). e1815–e1815. 2 indexed citations
4.
Petschnigg, Julia, Bella Groisman, Max Kotlyar, et al.. (2014). The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nature Methods. 11(5). 585–592. 115 indexed citations
5.
Gilchrist, Mark, William R. Henderson, Carrie D. Johnson, et al.. (2010). A key role for ATF3 in regulating mast cell survival and mediator release. Blood. 115(23). 4734–4741. 30 indexed citations
6.
Hawn, Thomas R., Elizabeth Ann Misch, Sarah J. Dunstan, et al.. (2007). A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. European Journal of Immunology. 37(8). 2280–2289. 159 indexed citations
7.
Andersen‐Nissen, Erica, Thomas R. Hawn, Kelly D. Smith, et al.. (2007). Cutting Edge: Tlr5 −/− Mice Are More Susceptible to Escherichia coli Urinary Tract Infection. The Journal of Immunology. 178(8). 4717–4720. 154 indexed citations
8.
Hawn, Thomas R., Annelies Verbon, Kamilla D. Lettinga, et al.. (2003). A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease. The Journal of Experimental Medicine. 198(10). 1563–1572. 467 indexed citations breakdown →
9.
Jessup, J. Milburn, Joseph Locker, Alex Nachman, et al.. (2000). MICROGRAVITY CULTURE REDUCES APOPTOSIS AND INCREASES THE DIFFERENTIATION OF A HUMAN COLORECTAL CARCINOMA CELL LINE. In Vitro Cellular & Developmental Biology - Animal. 36(6). 367–367. 43 indexed citations
10.
Mizoi, Takayuki, et al.. (1998). Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells.. PubMed. 58(7). 1524–31. 34 indexed citations
11.
Jessup, J. Milburn, David R. Brown, Wendy Fitzgerald, et al.. (1997). Induction of carcinoembryonic antigen expression in a three-dimensional culture system. In Vitro Cellular & Developmental Biology - Animal. 33(5). 352–357. 32 indexed citations
12.
Edmiston, Kirsten H., A. Gangopadhyay, Yutaka Shoji, et al.. (1997). In vivo induction of murine cytokine production by carcinoembryonic antigen.. PubMed. 57(19). 4432–6. 40 indexed citations
13.
Ishii, Shoken, et al.. (1993). CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surgical Oncology. 2(4). 255–264. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026